Amanote Research

Amanote Research

    RegisterSign In

The Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire Upon Generic Entry?

PLoS Medicine - United States
doi 10.1371/journal.pmed.1001955
Full Text
Open PDF
Abstract

Available in full text

Categories
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
Date

February 9, 2016

Authors
Ameet SarpatwariAaron S. Kesselheim
Publisher

Public Library of Science (PLoS)


Related search

Brand-Name Versus Generic: The Authors Respond

Health Affairs
MedicineHealth Policy
2007English

The Concept Of: Generic Drugs and Patented Drugs vs. Brand Name Drugs and Non-Proprietary (Generic) Name Drugs

Frontiers in Pharmacology
Pharmacology
2013English

Consumer Price Differentials Between Generic and Brand Name Prescriptions.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1974English

Higher Prices From Entry: Pricing of Brand-Name Drugs

SSRN Electronic Journal
1995English

Naming Into the Brand System

State University of Telecommunications
2019English

Naming Shirehampton and the Name Shirehampton

Onoma
2015English

Brand Name or Generic Drugs: A National Survey of Patient Perception and Preferences

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Willingness to Pay (WTP) for a Brand Name Drug in Sâo Paulo, Brazil

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Generic Scrip Share and the Price of Brand-Name Drugs: The Role of the Consumer

2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy